Travere Therapeutics to Participate at Upcoming Investor Conferences
Rhea-AI Summary
Travere Therapeutics (NASDAQ: TVTX) has announced its participation in four major investor conferences during March 2025. The company will present at the TD Cowen 45th Annual Health Care Conference on March 3 at 9:10 a.m. ET and the Leerink Partners Global Biopharma Conference on March 11 at 9:20 a.m. ET. Additional appearances include the Barclays 27th Annual Global Healthcare Conference and Jefferies Biotech on the Beach Summit, both scheduled for March 12.
Live webcasts will be available for the TD Cowen and Leerink Partners conference presentations through Travere's investor relations website at ir.travere.com/events-presentations. These webcasts will remain accessible for replay up to 30 days after each event.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, TVTX declined 2.73%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
SAN DIEGO, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that company management will participate in the following upcoming investor conferences in March:
TD Cowen 45th Annual Health Care Conference
Presenting on Monday, March 3, 2025, at 9:10 a.m. ET
Leerink Partners Global Biopharma Conference
Presenting on Tuesday, March 11, 2025, at 9:20 a.m. ET
Barclays 27th Annual Global Healthcare Conference
Wednesday, March 12, 2025
Jefferies Biotech on the Beach Summit
Wednesday, March 12, 2025
Live webcasts of the TD Cowen 45th Annual Health Care Conference and Leerink Partners Global Biopharma Conference presentations will be accessible on the Investor page of Travere’s website at ir.travere.com/events-presentations. Replays will be available for up to 30 days following each event.
About Travere Therapeutics
At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop, and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com.
Contact:
| Investors: 888-969-7879 IR@travere.com | Media: 888-969-7879 mediarelations@travere.com |
FAQ
When is Travere Therapeutics (TVTX) presenting at the TD Cowen Healthcare Conference in March 2025?
Which investor conferences will TVTX attend in March 2025?
How long will TVTX conference presentation webcasts be available for replay?
Where can investors access Travere Therapeutics' (TVTX) conference presentation webcasts?
Which TVTX conference presentations in March 2025 will have live webcasts available?
